19 December 2014
Yesterday’s Research Excellence Framework 2014 (REF2014) results have rated UCL the top university in the UK for research strength.
Included in the case studies submitted for REF2014 were UCLB spinout companies; Pentraxin Therapeutics, Polytherics, Space Syntax, Helicon Health, Spirogen and Senceive as well as numerous successful technologies.
UCLB is essential in the commercialisation of university research; the success of these case studies highlights the importance of using university research to maximise impact on the community.
To read the full UCL article click here.
About UCL Business PLC
UCL Business PLC (UCLB) is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK’s top research-led universities. UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. UCLB has a strong track record in commercialising medical technologies and provides technology transfer services to UCL’s associated hospitals; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London Hospital. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market.
For further information, please visit: www.uclb.com